Search Results

You searched for : Hikma

	Hyloris announces FDA acceptance of new drug application for Maxigesic IV in post-operative pain Latest pharma news update... Nov 03
	Hikma strengthens US Injectables business through acquisition of Custopharm Latest pharma update... Sep 29
	Glenmark collaborates with Menarini for commercializing Ryaltris nasal spray across Europe The licensing agreement will be effective in 33 countries throughout the European region including France, Italy, and Spain... Dec 23
	Gilead Seeks US Approval For Drug That Shortens Covid Recovery Time The antiviral drug, which helped shorten the hospital recovery time in a U.S. trial, has been at the forefront of the battle against the ... Aug 11
	Hikma receives FDA approval for the generic version of Vascepa Hikma receives FDA approval for Icosapent Ethyl capsules... May 25
	Hikma Announces the Launch of Propofol Injectable Emulsion, USP Hikma responds to COVID-19 shortage with launch of Propofol Injectable Emulsion, USP. Sedative for patients on ventilators currently in short supply in the US ... May 12
	Glenmark Pharma Signs an Exclusive Licensing Agreement with Hikma Pharmaceuticals Under the terms of the agreement, Glenmark will be responsible for the continued development and regulatory approval of Ryaltrisâ„¢ by the US FDA, while Hikma ... Feb 28
7 Matching result(s) found!

-Advertisements-

Trending Now
	Scientists in Moscow Develop Fetal Phantom for Obstetric UltrasoundNovember 19, 2024
	International Men’s Day: A Celebration of Strength, Vulnerability, and ChangeNovember 19, 2024
	The Bloody Truth: Why Menstruation Is Still a Taboo in Indian SchoolsNovember 19, 2024
	Toxic Air, Fragile Hearts: The Hidden Cost of Pollution on Heart Failure PatientsNovember 19, 2024
	Government of Telangana Hosts the AI in Healthcare Summit – Road to BioAsia 2025November 18, 2024
	In yet another groundbreaking medical milestone, Sarvodaya Hospital successfully performs India’s youngest cochlear implant on a 5- month old babyNovember 18, 2024
	Sightsavers India in collaboration with AbbVie Therapeutics India Private Limited Hosted the 4th State-Level Consultation on ‘Prevention of Visual Impairment Caused by Glaucoma’November 16, 2024
	Is Your Saree Hurting You? How Tight Waist Petticoats Could Trigger Skin CancerNovember 16, 2024
	10 New-born Lives Lost: The Jhansi Hospital Fire That Shook India’s ConscienceNovember 16, 2024
	Streax introduces revolutionary Shampoo Hair Colour in South India at accessible price point.November 15, 2024
	The Silent Killer in Your Genes: Can Splicing Errors Unlock New Cancer Cures?November 15, 2024
	Stress on a Schedule: What Your Gut Bacteria Know That You Don’tNovember 15, 2024
	A Preventable Catastrophe: Why Are Children Still Dying from Measles?November 15, 2024
	The University of Tasmania invites applications for Master of Marine and Antarctic ScienceNovember 14, 2024
	ICMR’s Bold Bet: Can India’s Scientists Deliver World-First Health Breakthroughs?November 14, 2024
	The Dark Reality Behind India’s Ayushman Bharat: Profits Before Patients?November 14, 2024
	Not a Fan of Exercise? Here’s How Few Steps You Actually Need for Better HealthNovember 14, 2024
	Shiprocket launches AI Powered Shiprocket Copilot to empower a Self-Reliant Digital Future for over 1,00,000+ Indian MSMEsNovember 13, 2024
	AIIMS Darbhanga and More: Can PM Modi’s 12,000 Crore Investment Turn Bihar into India’s Next Growth Engine?November 13, 2024
	Self-Made Survivor: How a Virologist Battled Breast Cancer with Her Own Lab-Grown VirusesNovember 13, 2024

Search Results

Hyloris announces FDA acceptance of new drug application for Maxigesic IV in post-operative pain

Hikma strengthens US Injectables business through acquisition of Custopharm

Glenmark collaborates with Menarini for commercializing Ryaltris nasal spray across Europe

Gilead Seeks US Approval For Drug That Shortens Covid Recovery Time

Hikma receives FDA approval for the generic version of Vascepa

Hikma Announces the Launch of Propofol Injectable Emulsion, USP

Glenmark Pharma Signs an Exclusive Licensing Agreement with Hikma Pharmaceuticals

Trending Now